Related Experiment Video
Updated: May 9, 2026
08:06
The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
β-Lactamase inhibitors: an update
Jiao Chen1, Xiaohui Shang, Feng Hu
1School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, P.R. China. zhengh18@hotmail.com.
Mini Reviews in Medicinal Chemistry
|July 31, 2013
Summary
The rise of β-lactamase resistance threatens antibiotic effectiveness. New inhibitors are needed, especially for metallo-β-lactamases, to combat resistant bacterial infections.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Pharmacology
Background:
- Antimicrobial resistance, particularly β-lactamase-mediated resistance to β-lactam antibiotics, poses a significant clinical challenge.
- Current treatments rely on β-lactamase inhibitors (e.g., clavulanic acid) effective against Class A enzymes, but not Classes B, C, or D.
Purpose of the Study:
- To review recent advancements in the discovery of β-lactamase inhibitors.
- To highlight the urgent need for broad-spectrum inhibitors, particularly for metallo-β-lactamases (Class B).
Main Methods:
- Literature review of recent studies on β-lactamase inhibitor development.
- Analysis of the current landscape of inhibitor discovery, focusing on different β-lactamase classes.
Main Results:
- Significant progress has been made in developing inhibitors for serine β-lactamases (Class A, C), with some in clinical trials.
- Despite numerous active molecules reported, no promising metallo-β-lactamase (Class B) inhibitors with good druggability have been identified.
Conclusions:
- There is a critical need for novel β-lactam antibiotics or broad-spectrum β-lactamase inhibitors to address resistance.
- Further research is essential to discover effective inhibitors for metallo-β-lactamases to combat challenging bacterial infections.
More Related Videos
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...